EA
TMDX icon

Evolution Advisers’s Transmedics TMDX Stock Holding History

Evolution Advisers’s Portfolio TMDX Stock Details TMDX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$0 Buy
+4
New +$339 ﹤0.01% 829

Other funds holding TMDX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
NAMI
Nomura Asset Management International Philadelphia, Pennsylvania $66.6B AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
HRCM
Hood River Capital Management Palm Beach Gardens, Florida $13.8B AUM 163.97% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $2.7B AUM 88.53% 1-Year Est. Return

Evolution Advisers's TMDX Position: Q2 2026 in Review

Evolution Advisers opened a new position in Transmedics (TMDX) in Q2 2026: 4 shares worth $0. The stake represents ﹤0.01% of the portfolio and ranks #829 among its holdings.

372 funds tracked by Wall St. Rank hold TMDX as of Q2 2026.

  • Evolution Advisers held 4 shares of Transmedics worth $0 as of Q2 2026.
  • Transmedics was a new Evolution Advisers position in Q2 2026.
  • Transmedics made up ﹤0.01% of Evolution Advisers's portfolio in Q2 2026, its #829 holding.
  • 372 funds tracked by Wall St. Rank held Transmedics as of Q2 2026.

Based on Evolution Advisers's 13F filing for Q2 2026, filed 31 Jul 2026.